SCHEMBL879745

SCHEMBL879745

Cc1cc(N2C(=O)CC[C@@H]2C)cc(C)c1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.44
TSHR P16473 2/20 0.44
ALDH1A1 P00352 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAP4K1 Q92918 1/20 0.38
ABL1 P00519 2/20 0.37
P2RX3 P56373 2/20 0.37
P2RX2 Q9UBL9 2/20 0.37
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
PARP1 P09874 1/20 0.33
RAPGEF3 O95398 2/20 0.33
RAPGEF4 Q8WZA2 2/20 0.33
BRD4 O60885 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16691744 0.81 NPSR1 (0.40) NPSR1MAP4K1ABL1P2RX3P2RX2
SCHEMBL879707 0.80 TSHR (0.41) POLBTSHRALDH1A1NPSR1HSD17B10
SCHEMBL850490 0.78 ALDH1A1 (0.40) POLBTSHRALDH1A1NPSR1HSD17B10
SCHEMBL850491 0.78 ALDH1A1 (0.40) POLBTSHRALDH1A1NPSR1HSD17B10
SCHEMBL16480407 0.77 PER2 (0.40) MAP4K1ABL1P2RX3P2RX2SLC6A2
SCHEMBL16480426 0.76 SLC6A2 (0.53) ALDH1A1ABL1SLC6A2SLC6A4SLC6A3
SCHEMBL9893055 0.76 PARP1 (0.43) ABL1SLC6A2SLC6A4SLC6A3CCNA2
SCHEMBL849497 0.76 TSHR (0.38) POLBTSHRALDH1A1NPSR1HSD17B10
SCHEMBL849498 0.76 TSHR (0.38) POLBTSHRALDH1A1NPSR1HSD17B10
SCHEMBL10131414 0.76 CYP3A4 (0.41) TSHRABL1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010126030-A1 SPIROIMIDAZOLONE DERIVATIVE 中外製薬株式会社 (JP) 2010-11-04 WO disclosed